Brazil Oncology Clinical Trials Market Analysis

Brazil Oncology Clinical Trials Market Analysis

$ 3999

Brazil's oncology clinical trials market is projected to grow from $316.3 Mn in 2022 to $523.4 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. The market will be driven by the increased investment in healthcare and research and the rise in oncology clinical trials owing to rising cancer cases in Brazil. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International AG & Eurofarma Laboratórios S.A.

ID: IN10BRCT006 CATEGORY: Clinical Trials GEOGRAPHY: Brazil AUTHOR: Vidhi Upadhyay

Buy Now

Brazil Oncology Clinical Trials Market Executive Summary

Brazil's oncology clinical trials market is projected to grow from $316.3 Mn in 2022 to $523.4 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. Brazil is a vast nation with a population of over 200 Mn people, distinct geographical characteristics, and substantial health inequities. Although 25% of the Brazilian population has some sort of private insurance, the vast majority of people are served by the public system, known as the Sistema Nacional de Sade (SUS). Most, but not all, private insurance plans give access to cutting-edge cancer therapies. The public system, on the other hand, has generally denied coverage for newer, more expensive cancer treatments. As a consequence, treating patients based on current clinical trial findings, which have demonstrated tremendous improvements in outcomes in many cancer types, is helpful yet not feasible for the bulk of the country's population. According to Globocan 2020, In Brazil 5,92,212 new incidences of cancer were recorded with 2,59,949 fatalities.

Brazil is one of Latin America's biggest and fastest-growing pharmaceutical markets, and the country has a strong clinical trial infrastructure, making it an appealing venue for oncology clinical trials. Oncology clinical trials are conducted in Brazil by a variety of prestigious academic and research institutes. The major institutes are;

  • Brazilian National Cancer Institute (INCA)
  • Hospital das Clinicas in So Paulo
  • Instituto do Câncer do Estado de So Paulo (ICESP)

With a solid infrastructure, a diversified patient population, and a supportive regulatory framework, the oncology clinical trials picture in Brazil is promising. Ongoing investment in research infrastructure, patient education, and international partnerships may assist to propel clinical trials in Brazil forward.

brazil oncology clinical trials market analysis

Market Dynamics

Market Growth Drivers

In recent years, Brazil has increased its investment in healthcare and research, including efforts like the Brazilian National Cancer Institute's (INCA) 2020-2023 strategy plan to boost cancer research and treatment. Brazil has a variety of renowned academic and research institutes active in oncology clinical trials, offering knowledge and resources to help with clinical research. Moreover, the rise of oncology clinical trials in Brazil is being driven by a supportive regulatory framework and a big and diversified population, which provides a vast pool of prospective patients for clinical studies.

Market Restraints

Despite the fact that Brazil has a big and diversified population, access to healthcare is restricted in certain locations, notably in rural and low-income areas. This may make recruiting participants for clinical studies difficult and restrict the generalizability of study outcomes. In Brazil, patients and doctors are still unaware of clinical trials, making it difficult to recruit patients for studies and restricting involvement in clinical research. Although the regulatory climate in Brazil for clinical trials is generally favorable, there are certain limitations, such as lengthy approval timeframes and bureaucratic impediments that might delay or hinder clinical trial implementation.

Competitive Landscape

Key Players

  • Pfizer Inc.
  • Novartis International AG
  • Roche Holding AG
  • AstraZeneca plc
  • Bristol Myers Squibb Company
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Johnson & Johnson
  • Sanofi S.A.
  • Aché Laboratórios Farmacêuticos S.A (BRA)
  • Cristália Produtos Químicos Farmacêuticos Ltda (BRA)
  • Eurofarma Laboratórios S.A. (BRA)
  • Libbs Farmacêutica Ltda (BRA)

Notable Insights

  1. November 2022, BeiGene Reports BRUKINSA® Approval in Brazil for the Treatment of Rare Blood Cancers
  2. In April 2021, PlantForm Corporation (PlantForm) of Canada struck a deal with Brazilian partners to create a biosimilar of the cancer medicine pembrolizumab (Keytruda). Pembrolizumab is an antibody that is used to treat a variety of cancers, including lung, stomach, and head and neck cancer. It inhibits the immune system's ability to recognize and kill cancer cells by targeting the protein PD-1

Healthcare Policies and Regulatory Landscape

The National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária (ANVISA)) is the regulatory body in charge of clinical trial monitoring, drug licensing, and inspection in Brazil. ANVISA authorizes the conduct of clinical studies. ANVISA is led by a Collegiate Board of Directors comprised of up to five (5) members, one (1) of whom acts as CEO. The Collegiate Board's major tasks include setting ANVISA's strategic guidelines and recommending to the Minister governmental policies and directives in support of the agency's sanitary surveillance goals.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Oncology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design Outlook (Revenue, USD Billion):

  • Epilepsy
  • Parkinson's Disease (PD)
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Others

By Indication Outlook  (Revenue, USD Billion):

  • Interventional
  • Observational
  • Expanded Access

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 20 March 2023
Updated by: Bhanu Pratap Singh

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter